Diagnostic On-Site

Diagnostic On-Site

Single Panel Fentanyl

Single Panel Drug Urine Rapid Test detects 1 substance with specific result for the substance analyzed.  This urine drug test detects: FYL20.

SKU: SC-1828-25 Categories: , Tags: , ,

Product information

Single Panel Drug Urine Rapid Test detects 1 substance with specific result for the substance analyzed.  This urine drug test detects: FYL20.

 

Advantages of Urine test

  • Easy to collect
  • No limit to sample volume
  • Long detection window 

 

General information

The Single Panel Fentanyl (Urine) is a rapid immunochromatographic test for the detection of Norfentanyl, a metabolite of Fentanyl. It is a powerful narcotic analgesic, the abuse of which induces addiction or dependence. It is primarily a mu-opioid agonist. Norfentanyl is also used in conjunction with other generic anesthetics and as an anesthetic for induction and maintenance.

Fentanyl belongs to the potent narcotic analgesics and is a special μ-opioid receptor stimulant. Fentanyl is one of the variants listed in the United Nations “Single Convention on Narcotic Drugs of 1961”. Among the internationally controlled opioid agents, Fentanyl is one of the most commonly used for the treatment of moderate to severe pain.

Following repeated injections of Fentanyl, the patient will have a protracted opioid withdrawal syndrome, such as ataxia and irritability, etc. which leads to addiction after taking Fentanyl for long periods of time. Compared with amphetamine addicts, Fentanyl addicts have a higher risk rate of HIV infection, a more severe injection habit and risk of drug overdose during their lifetime. The FYL rapid test (Urine) is a rapid urine control test that can be performed without the use of instruments.

The test uses a monoclonal antibody to selectively detect high levels of Norfentanyl in urine. The FYL rapid test (Urine) gives a positive result when the Norfentanyl in the urine exceeds 20 ng/mL.

 

Test procedure

Interpret results within minutes for simultaneous specimen collection and screening.

  1. Allow the test, urine specimen, and/or controls to reach room temperature (15-30ºC) prior to testing.
  2. Bring the pouch to room temperature before opening it. Remove the test panel from the sealed pouch and use it within one hour.
  3. Remove the cap.
  4. With the arrow pointing toward the urine specimen, immerse the test panel vertically in the urine specimen for at least 10 to 15 seconds. Immerse the dipstick to at least the level of the wavy lines, but not above the arrow on the test panel.
  5. Replace the cap and place the test panel on a non-absorbent flat surface.
  6. Start the timer and wait for the colored line(s) to appear.
  7. The drug strip result should be read at 5 minutes. Do not interpret the result after 10 minutes.

 

Interpretation of the results

Negative result:* A colored line appears in the Control region (C) and colored lines appear in the Test region (T). This negative result means that the concentrations in the urine sample are below the designated cut-off levels for a particular drug tested.

*NOTE: The shade of the colored lines(s) in the Test region (T) may vary. The result should be considered negative whenever there is even a faint line.

Positive result: A colored line appears in the Control region (C) and NO line appears in the Test region (T). The positive result means that the drug concentration in the urine sample is greater than the designated cut-off for a specific drug.

Invalid result: No line appears in the Control region (C). Insufficient specimen volume or incorrect procedural techniques are the most likely reasons for Control line failure. Read the directions again and repeat the test with a new test card. If the result is still invalid, contact us.

 


 

Product name

Single Panel Fentanyl

Detection

FYL20

Type

Sample Type

Pack Size

Format

Analyte Detection

For Drug Test